289 related articles for article (PubMed ID: 1911585)
1. Pretreatment of the primigravid uterine cervix with mifepristone 30 h prior to termination of pregnancy: a double blind study.
Cohn M; Stewart P
Br J Obstet Gynaecol; 1991 Aug; 98(8):778-82. PubMed ID: 1911585
[TBL] [Abstract][Full Text] [Related]
2. Pre-operative cervical preparation before first trimester vacuum aspiration: a randomized controlled comparison between gemeprost and mifepristone (RU 486).
Henshaw RC; Templeton AA
Br J Obstet Gynaecol; 1991 Oct; 98(10):1025-30. PubMed ID: 1751434
[TBL] [Abstract][Full Text] [Related]
3. Effect of mifepristone on dilatation of the pregnant and non-pregnant cervix.
Gupta JK; Johnson N
Lancet; 1990 May; 335(8700):1238-40. PubMed ID: 1971320
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of progesterone antagonist RU486 (mifepristone) for pre-operative cervical dilatation during first trimester abortion.
Durlot F; Dubois C; Brunerie J; Frydman R
Hum Reprod; 1988 Jul; 3(5):583-4. PubMed ID: 3170699
[TBL] [Abstract][Full Text] [Related]
5. Should we use prostaglandins, tents or progesterone antagonists for cervical ripening before first trimester abortion?
Gupta JK; Johnson N
Contraception; 1992 Nov; 46(5):489-97. PubMed ID: 1458895
[TBL] [Abstract][Full Text] [Related]
6. Cervical dilatation with 16,16-dimethyl-trans-delta 2-PGE1 methyl ester (Cervagem) prior to vacuum aspiration. A double-blind, placebo-controlled randomized study.
Christensen NJ; Bygdeman M
Contraception; 1984 May; 29(5):457-64. PubMed ID: 6378517
[TBL] [Abstract][Full Text] [Related]
7. Mifepristone (RU486) and therapeutic late pregnancy termination: a double-blind study of two different doses.
Frydman R; Fernandez H; Pons JC; Ulmann A
Hum Reprod; 1988 Aug; 3(6):803-6. PubMed ID: 3065355
[TBL] [Abstract][Full Text] [Related]
8. Mifepristone (RU 486) for cervical priming prior to surgically induced abortion in the late first trimester.
Urquhart DR; Templeton AA
Contraception; 1990 Aug; 42(2):191-9. PubMed ID: 2085969
[TBL] [Abstract][Full Text] [Related]
9. Controlled study of 16,16-dimethyl-trans-delta 2 prostaglandin E1 methyl ester vaginal pessaries prior to suction termination of first trimester pregnancies.
Fisher PR; Taylor JH
Br J Obstet Gynaecol; 1984 Nov; 91(11):1141-4. PubMed ID: 6388625
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of various intracervically administered PG gel preparations for termination of first trimester pregnancies.
Rath W; Meyer D; Hildebrandt J; Hilgers R; Kuhn W
Contraception; 1983 Sep; 28(3):209-22. PubMed ID: 6357631
[TBL] [Abstract][Full Text] [Related]
11. Dilatation of the cervix by oral PGE2 before first-trimester termination of pregnancy.
Somell C; Olund A; Kindahl H; Larsson B
Acta Obstet Gynecol Scand; 1984; 63(7):625-8. PubMed ID: 6393687
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment with mifepristone (RU 486) reduces interval between prostaglandin administration and expulsion in second trimester abortion.
Rodger MW; Baird DT
Br J Obstet Gynaecol; 1990 Jan; 97(1):41-5. PubMed ID: 2407284
[TBL] [Abstract][Full Text] [Related]
13. Medical abortion in women of less than or equal to 56 days amenorrhoea: a comparison between gemeprost (a PGE1 analogue) alone and mifepristone and gemeprost.
Norman JE; Thong KJ; Rodger MW; Baird DT
Br J Obstet Gynaecol; 1992 Jul; 99(7):601-6. PubMed ID: 1525104
[TBL] [Abstract][Full Text] [Related]
14. A study of gemeprost alone, dilapan or mifepristone in combination with gemeprost for the termination of second trimester pregnancy.
Thong KJ; Baird DT
Contraception; 1992 Jul; 46(1):11-7. PubMed ID: 1424619
[TBL] [Abstract][Full Text] [Related]
15. Termination of second trimester pregnancy with sulprostone and mifepristone: a randomized double-blind placebo-controlled trial.
Ho PC; Ma HK
Contraception; 1993 Feb; 47(2):123-9. PubMed ID: 8449013
[TBL] [Abstract][Full Text] [Related]
16. Cervical ripening with mifepristone (RU 486) in late first trimester abortion. World Health Organization Task Force on Postovulatory Methods of Fertility Regulation.
Contraception; 1994 Nov; 50(5):461-75. PubMed ID: 7859455
[TBL] [Abstract][Full Text] [Related]
17. Intracervical administration of prostaglandin E2-gel prior to therapeutic abortion: a prospective randomized double-blind study.
Shalev E; Tsabari A; Edelstein S; Weiner E; Zuckerman H
Int J Gynaecol Obstet; 1988 Aug; 27(1):119-22. PubMed ID: 2905287
[TBL] [Abstract][Full Text] [Related]
18. A Gemeprost vaginal suppository for cervical priming prior to termination of first trimester pregnancy.
Kajanoja P; Mandelin M; Mäkilä UM; Ylikorkala O; Felding C; Somell C; Olund A; Pedersen H
Contraception; 1984 Mar; 29(3):251-60. PubMed ID: 6539662
[TBL] [Abstract][Full Text] [Related]
19. The use of mifepristone (RU 486) for cervical preparation in first trimester pregnancy termination by vacuum aspiration. World Health Organization. Task Force on Post-ovulatory Methods for Fertility Regulation.
Br J Obstet Gynaecol; 1990 Mar; 97(3):260-6. PubMed ID: 2185822
[TBL] [Abstract][Full Text] [Related]
20. Early pregnancy termination: a comparison between vacuum aspiration and medical abortion using prostaglandin (16,16 dimethyl-trans-delta 2-PGE1 methyl ester) or the antiprogestogen RU 486.
Cameron IT; Baird DT
Br J Obstet Gynaecol; 1988 Mar; 95(3):271-6. PubMed ID: 3370199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
